
NYSEHealthcareMedical - Diagnostics & Research
最新数据
US$440.45
−US$16.03 · -3.51%
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
前收盘价
US$440.45
−US$16.03 · -3.51%
盘中时间采用ET。市场数据可能有所延迟。
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
日内区间
当前US$440.45
52周区间
当前US$440.45
盘中时间采用ET。市场数据可能有所延迟。
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
日内区间
当前US$440.45
52周区间
当前US$440.45
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 31.65亿 USD | 29.58亿 USD | 29.56亿 USD | 29.72亿 USD | 27.86亿 USD |
| 销货成本 | 12.89亿 USD | 12亿 USD | 11.95亿 USD | 12.48亿 USD | 11.57亿 USD |
| 毛利 | 18.76亿 USD | 17.58亿 USD | 17.61亿 USD | 17.24亿 USD | 16.29亿 USD |
| 研究与开发 | 1.96亿 USD | 1.83亿 USD | 1.75亿 USD | 1.76亿 USD | 1.68亿 USD |
| 销售、一般及管理费用 | 8.3亿 USD | 6.9亿 USD | 7.36亿 USD | 6.58亿 USD | 6.27亿 USD |
| 营业费用 | 10.74亿 USD | 9.32亿 USD | 9.44亿 USD | 8.5亿 USD | 8.08亿 USD |
| 利息收入 | 1877.7万 USD | 1741.6万 USD | 1662.1万 USD | 1102万 USD | 1222.1万 USD |
| 利息支出 | 6954.8万 USD | 8967.7万 USD | 9886.1万 USD | 4879.7万 USD | 4493.8万 USD |
| 折旧和摊销 | 2.06亿 USD | 1.92亿 USD | 1.66亿 USD | 1.3亿 USD | 1.32亿 USD |
| 营业利润 | 8.03亿 USD | 8.26亿 USD | 8.18亿 USD | 8.73亿 USD | 8.22亿 USD |
| 净利润 | 6.43亿 USD | 6.38亿 USD | 6.42亿 USD | 7.08亿 USD | 6.93亿 USD |
公司数据更新于 2026年11月22日。
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2000年8月28日 | 2:1 | — | — |
股票拆分 | 1999年6月11日 | 2:1 | — | — |
已生效 2000年8月28日
2:1
已生效 1999年6月11日
2:1
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T867.38亿0.07%119.93万亿 JPY0.09%JP¥113,700-3.19%
Vanguard S&P 500 ETFVOO12.08亿0.07%1万亿 USD0.03%US$635.54-3.41%
Vanguard Morningstar Total Stock Market ETFVTI11.39亿0.06%6893亿 USD0.03%US$340.02-3.52%
Vanguard Morningstar Mid-Cap ETFVO9.71亿0.44%1074亿 USD0.03%US$76.25-2.22%
iShares Core S&P 500 ETFIVV5.82亿0.07%8034.1亿 USD0.03%US$693.71-3.52%
State Street SPDR S&P 500 ETFSPY5.47亿0.07%7563.79亿 USD0.09%US$689.81-3.64%
Vanguard Morningstar Mid-Cap Growth ETFVOT3.55亿1.09%187亿 USD0.05%US$263.71-3.73%
Vanguard Morningstar Growth ETFVUG3.49亿0.09%2210亿 USD0.03%US$75.69-5.32%
State Street SPDR S&P 500 ETF1557.T
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Mid-Cap ETFVO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Mid-Cap Growth ETFVOT
Vanguard Morningstar Growth ETFVUGAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。